Clinical Trials in China / NCT03233087
Recruiting
Observational
Diagnosis and Prognosis for Aortic Aneurysm aNd Dissection in Anzhen(DPANDA) Study
NCT03233087 · tracked via the Priya Life Science China tracker
Condition(s) studied
Aortic AneurysmAortic Dissection
Study summary
The registry study aims to determine serial biomarkers to diagnosis and prognosis of aortic aneurysm/aortic dissection.
Eligibility
Inclusion Criteria:
Retrospective
* All patients who were referred to the surgical service for evaluation and management of aortic dissection were included.
Perspective
* Patients with initial suspicion of having AAD were perspectively enrolled.
Exclusion Criteria:
Retrospective
* Patients who received packed red blood cells, whole blood, or platelets less than 10 days before the blood sample was taken;
* Patients with aortic trauma, pseudo aneurysm, history of heart failure, renal dysfunction, severe pulmonary diseases, or active cancer;
* Patients who entered the hospital for checkups after surgery.
Perspective
* Patients in whom there is little or no suspicion of a life-threatening disease;
* Patients with confirmed acute myocardial infarction,angina or pulmonary embolism
* The symptoms were clearly not related to AD (e.g. pleurisy, pneumonia, acute abdominal diseases).
Primary outcome measure(s)
- Dignosis of each participant — These data is collected from the cases' medical record in an average of 6 month after the sample recruiting
1. Patients with Aneurysm/Dissection had image information from ultrasound cardiograms and computed tomography to confirm the final diagnosis. 2. AMI if they had chest pain lasting \>20 min, diagnostic serial ECG changes comprising new pathological Q waves or ST-segment and T-wave changes, and a plasma creatine kinase-MB elevation greater than twice the normal level or cardiac troponin I (cTnI) level greater than 0.1 ng/mL. 3. Diagnosis of PE was confirmed by positive spiral computed tomography or pulmonary angiography, a high probability on ventilation perfusion scintigraphy, or a proximal deep vein thrombosis documented on compression ultrasonography or angiography. - Prognosis of each participant — These data is collected from the cases' medical record or during follow-up visit at 2-4 years after discharge.
Prognosis information including all-cause mortality and in-hospital mortality.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Beijing Anzhen Hospital | Beijing | Beijing Municipality | Recruiting |
More Beijing Institute of Heart, Lung and Blood Vessel Diseases trials in China
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03233087 on ClinicalTrials.gov ↗ ← All trials in China